Takao Arimori

Takao Arimori

Auto-generated profile, based on publicly available information

Takao Arimori

The University of Osaka

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2017 in Nature
Verified
Journal Article
Open access
PDF file
FSFumiji Saito
Fumiji Saito
KHKouyuki Hirayasu
Kouyuki Hirayasu
TSTakeshi Satoh
Takeshi Satoh
CWChristian W. Wang
Christian W. Wang
JLJohn Lusingu
John Lusingu
HAHisashi Arase
Hisashi Arase
Proteins expressed on the surfaces of erythrocytes infected with Plasmodium falciparum help the parasite to evade the host immune system by acting as ligands for immune inhibitory receptors and thereby downregulating the immune response. The malaria parasite, Plasmodium falciparum, uses several strategies to evade the host immune system during infection. Here, the authors report that a subset of parasite-derived ligands from the RIFIN protein family, which are expressed on the surface of infected red blood cells (erythrocytes), engage the immune inhibitory receptors leucocyte immunoglobulin-like receptor B1 (LILRB1) or leucocyte-associated immunoglobulin-like receptor 1 (LAIR1), which leads to the downregulation of immune responses. Malaria is among the most serious infectious diseases affecting humans, accounting for approximately half a million deaths each year1. Plasmodium falciparum causes most life-threatening cases of malaria. Acquired immunity to malaria is inefficient, even after repeated exposure to P. falciparum2, but the immune regulatory mechanisms used by P. falciparum remain largely unknown. Here we show that P. falciparum uses immune inhibitory receptors to achieve immune evasion. RIFIN proteins are products of a polymorphic multigene family comprising approximately 150–200 genes per parasite genome3 that are expressed on the surface of infected erythrocytes. We found that a subset of RIFINs binds to either leucocyte immunoglobulin-like receptor B1 (LILRB1) or leucocyte-associated immunoglobulin-like receptor 1 (LAIR1). LILRB1-binding RIFINs inhibit activation of LILRB1-expressing B cells and natural killer (NK) cells. Furthermore, P. falciparum-infected erythrocytes isolated from patients with severe malaria were more likely to interact with LILRB1 than erythrocytes from patients with non-severe malaria, although an extended study with larger sample sizes is required to confirm this finding. Our results suggest that P. falciparum has acquired multiple RIFINs to evade the host immune system by targeting immune inhibitory receptors.

21 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
YHYusuke Higuchi
Yusuke Higuchi
TSTatsuya Suzuki
Tatsuya Suzuki
TATakao Arimori
Takao Arimori
NINariko Ikemura
Nariko Ikemura
EMEmiko Mihara
Emiko Mihara
AHAtsushi Hoshino
Atsushi Hoshino
SARS-CoV-2 has mutated during the global pandemic leading to viral adaptation to medications and vaccinations. Here we describe an engineered human virus receptor, ACE2, by mutagenesis and screening for binding to the receptor binding domain (RBD). Three cycles of random mutagenesis and cell sorting achieved sub-nanomolar affinity to RBD. Our structural data show that the enhanced affinity comes from better hydrophobic packing and hydrogen-bonding geometry at the interface. Additional disulfide mutations caused the fixing of a closed ACE2 conformation to avoid off-target effects of protease activity, and also improved structural stability. Our engineered ACE2 neutralized SARS-CoV-2 at a 100-fold lower concentration than wild type; we also report that no escape mutants emerged in the co-incubation after 15 passages. Therapeutic administration of engineered ACE2 protected hamsters from SARS-CoV-2 infection, decreased lung virus titers and pathology. Our results provide evidence of a therapeutic potential of engineered ACE2.

29 April 2019 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
HHHidenori Hirai
Hidenori Hirai
KMKyoko Matoba
Kyoko Matoba
EMEmiko Mihara
Emiko Mihara
TATakao Arimori
Takao Arimori
JTJunichi Takagi
Junichi Takagi

29 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
TATakao Arimori
Takao Arimori
NMNaoyuki Miyazaki
Naoyuki Miyazaki
EMEmiko Mihara
Emiko Mihara
MTMamoru Takizawa
Mamoru Takizawa
YTYukimasa Taniguchi
Yukimasa Taniguchi
JTJunichi Takagi
Junichi Takagi
Recognition of laminin by integrin receptors is central to the epithelial cell adhesion to basement membrane, but the structural background of this molecular interaction remained elusive. Here, we report the structures of the prototypic laminin receptor α6β1 integrin alone and in complex with three-chain laminin-511 fragment determined via crystallography and cryo-electron microscopy, respectively. The laminin-integrin interface is made up of several binding sites located on all five subunits, with the laminin γ1 chain C-terminal portion providing focal interaction using two carboxylate anchor points to bridge metal-ion dependent adhesion site of integrin β1 subunit and Asn189 of integrin α6 subunit. Laminin α5 chain also contributes to the affinity and specificity by making electrostatic interactions with large surface on the β-propeller domain of α6, part of which comprises an alternatively spliced X1 region. The propeller sheet corresponding to this region shows unusually high mobility, suggesting its unique role in ligand capture.

1 July 2010 in Biochemistry
Verified
Journal Article
Closed access
MMMasanori Miyata
Masanori Miyata
TSTakashi Sato
Takashi Sato
MKMiyuki Kugimiya
Miyuki Kugimiya
MSMisato Sho
Misato Sho
TNTeruya Nakamura
Teruya Nakamura
HKHirofumi Kai
Hirofumi Kai

1 April 2016 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
YFYuki Fujii
Yuki Fujii
YMYukiko Matsunaga
Yukiko Matsunaga
TATakao Arimori
Takao Arimori
YKYu Kitago
Yu Kitago
SOSatoshi Ogasawara
Satoshi Ogasawara
JTJunichi Takagi
Junichi Takagi
Placement of a tag sequence is usually limited to either terminal of the target protein, reducing the potential of epitope tags for various labeling applications. The PA tag is a dodecapeptide (GVAMPGAEDDVV) that is recognized by a high-affinity antibody NZ-1. We determined the crystal structure of the PA tag/NZ-1 complex and found that NZ-1 recognized a central segment of the PA tag peptide in a tight β-turn configuration, suggesting its compatibility with the insertion into a loop. This possibility was tested and confirmed using multiple integrin subunits and semaphorin. More specifically, the PA tag can be inserted at multiple locations within the αIIb subunit of the fibrinogen receptor αIIbβ3 integrin without affecting the structural and functional integrity, while maintaining its high affinity toward NZ-1. The large choice of the sites for "epitope grafting" enabled the placement of the PA tag at a location whose accessibility is modulated during the biological action of the receptor. Thus, we succeeded in converting a general anti-tag antibody into a special reporter/activator anti-β1 integrin antibody that can be classified as a ligand-induced binding site antibody.